Inflammatory bowel disease in early childhood and adolescence: Special considerations

Gastroenterology Clinics of North America

Volumn 32, Issue 3, 2003, Pages 967-995

  Mamula, Petar ^a,b   Markowitz, Jonathan E ^a   Baldassano, Robert N ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; BONE DENSITY; CHILD; CHILD HEALTH CARE; COPING BEHAVIOR; CROHN DISEASE; ENTERITIS; GROWTH RETARDATION; HUMAN; NUTRITION; NUTRITIONAL DEFICIENCY; QUALITY OF LIFE; REVIEW; ULCERATIVE COLITIS;

EID: 0141682647     PISSN: 08898553     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8553(03)00046-3     Document Type: Review

References (164)

1. Cohen MB, Seidman E, Winter H, Colletti RB, Kirschner BS, Balistreri WF, et al. Controversies in pediatric inflammatory bowel disease. Inflamm Bowel Dis 1998;4:203-27.
2. Kim S, Ferry G. Inflammatory bowel diseases in children. Curr Probl Pediatr Adolesc Health Care 2002;32:108-32.
3. Baldassano RN, Piccoli DA. Inflammatory bowel disease in pediatric and adolescent patients. Gastroenterol Clin North Am 1999;28:445-58.
4. Fonager K, Sorensen HT, Olsen J. Change in incidence of Crohn's disease and ulcerative colitis in Denmark. A study based on the National Registry of Patients, 1981-1992. Int J Epidemiol 1997;26:1003-8.
5. Lindberg E, Lindquist B, Holmquist L, Hildebrand H. Inflammatory bowel disease in children and adolescents in Sweden, 1984 to 1995. J Pediatr Gastroenterol Nutr 2000;30:259-64.
6. Oliva-Hemker M, Fiocchi C. Etiopathogenesis of inflammatory bowel disease: the importance of the pediatric perspective. Inflamm Bowel Dis 2002;8:112-28.
7. Kirschner BS, Heyman M, Ferry G, Baldassano RN, Winter H, Cohen SA, et al. The pediatric IBD consortium database-initial demographic data. Gastroenterol 2002;122:A611.
8. Farmer RG, Michener WM. Prognosis of Crohn's disease with onset in childhood or adolescence. Dig Dis Sci 1979;24:752-7.
9. Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin N Am 1999;28:255-81.
10. Logan RF. Inflammatory bowel disease incidence: up, down or unchanged? Gut 1998;42:309-11.
11. Polito 2nd JM, Childs B, Mellits ED, Tokayer AZ, Harris ML, Bayless TM. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterol 1996;111:580-6.
12. Kugathasan S, Judd R, Khan F, Heikenen J, Brown C, Hoffman R. Epidemiologic and clinical characteristics of newly diagnosed inflammatory bowel disease children in the state of Wisconsin: results of a prospective state wide population based study. J Pediatr Gastroenterol Nutr 2002;35:A421.
13. Russel MG, Stockbrugger RW. Epidemiology of inflammatory bowel disease: an update. Scand J Gastroenterol 1996;31:417-27.
14. Bjornsson S, Johannsson JH, Oddsson E. Inflammatory bowel disease in Iceland, 1980-89. A retrospective nationwide epidemiologic study. Scand J Gastroenterol 1998;33:71-7.
15. Langholz E, Munkholm P, Krasilnikoff PA, Binder V. Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol 1997;32:139-47.
16. Askling J, Grahnquist L, Ekbom A, Finkel Y. Incidence of paediatric Crohn's disease in Stockholm. Sweden Lancet 1999;354:1179.
17. Barton JR, Gillon S, Ferguson A. Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983; marginal fall in ulcerative colitis, three-fold rise in Crohn's disease. Gut 1989;30:618-22.
18. Hildebrand H, Fredrikzon B, Holmquist L, Kristiansson B, Lindquist B. Chronic inflammatory bowel disease in children and adolescents in Sweden. J Pediatr Gastroenterol Nutr 1991;13:293-7.
19. Cosgrove M, Al-Atia RF, Jenkins HR. The epidemiology of paediatric inflammatory bowel disease. Arch Dis Child 1996;74:460-1.
20. Armitage E, Drummond HE, Wilson DC, Ghosh S. Increasing incidence of both juvenile-onset Crohn's disease and ulcerative colitis in Scotland. Eur J Gastroenterol Hepatol 2001;13:1439-47.
21. Tourtelier Y, Dabadie A, Tron I, Alexandre JL, Robaskiewicz M, Cruchant E, et al. Incidence of inflammatory bowel disease in children in Brittany (1994-1997). Breton association of study and research on digestive system diseases (Abermad). Arch Pediatr 2000;7:377-84.
22. Sawczenko A, Sandhu BK, Logan RF, Jenkins H, Taylor CJ, Mian S, et al. Prospective survey of childhood inflammatory bowel disease in the British Isles. Lancet 2001;357:1093-4.
23. Hassan K, Cowan FJ, Jenkins HR. The incidence of childhood inflammatory bowel disease in Wales. Eur J Pediatr 2000;159:261-3.
24. Gottrand F, Colombel JF, Moreno L, Salomez JL, Farriaux JP, Cortot A. Incidence of inflammatory bowel diseases in children in the Nord-Pas-de-Calais region. Arch Fr Pediatr 1991;48:25-8.
25. Bjornsson S, Johannsson JH. Inflammatory bowel disease in Iceland, 1990-1994: a prospective, nationwide, epidemiological study. Eur J Gastroenterol Hepatol 2000;12:31-8.
26. Olafsdottir EJ, Fluge G, Haug K. Chronic inflammatory bowel disease in children in western Norway. J Pediatr Gastroenterol Nutr 1989;8:454-8.
27. Royal College of Pediatricians and Child Health. Inflammatory bowel disease in under 20-year-olds. Royal College of Pediatricians and Child Health British Surveillance Unit 14th Annual report. London; 1999-2000. p. 25-7.
28. Tysk C, Lindberg E, Jarnerot G, Floderus-Myrhed B. Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. Gut 1988;29:990-6.
29. Cohen Z, Weizman Z, Kurtzbart E, Newman N, Kapuller V, Maor E, et al. Infantile colonic Crohn's disease: a report of four cases in one family. J Pediatr Gastroenterol Nutr 2000;30:461-3.
30. Hugot J-P, Chamaillard M, Zouali H, Lesage S, Cezard J-P, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001;411:599-603.
31. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001;411:603-6.
32. Montgomery SM, Pounder RE, Wakefield AJ. Infant mortality and the incidence of inflammatory bowel disease. Lancet 1997;349:472-3.
33. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
34. Duggan AE, Usmani I, Neal KR, Logan RF. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 1998;43:494-8.
35. Statter MB, Hirschl RB, Coran AC. Inflammatory bowel disease. Pediatr Clin North Am 1993;40:1213-31.
36. Hyams JS. Extraintestinal manifestations of inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 1994;19:7-21.
37. Heikenen JB, Werlin SL, Brown CW, Balint JP. Presenting symptoms and diagnostic lag in children with inflammatory bowel disease. Inflamm Bowel Dis 1999;5:158-60.
38. Kirschner BS. Inflammatory bowel disease in children. Pediatr Clin North Am 1988;35:189-208.
39. Gryboski JD. Crohn's disease in children 10 years old and younger: comparison with ulcerative colitis. J Pediatr Gastroenterol Nutr 1994;18:174-82.
40. Langholz E, Munkholm P, Krasilnikoff PA, Binder V. Inflammatory bowel diseases in children. Ugeskr Laeger 1998;160:5648-54.
41. O'Donoghue DP, Dawson AM. Crohn's disease in childhood. Arch Dis Child 1977;52:627-32.
42. Hofley PM, Piccoli DA. Inflammatory bowel disease in children. Med Clin North Am 1994;78:1281-302.
43. Griffiths A, Buller HB. Inflammatory Bowel Disease. In: Walker-Smith J, Durie PB, Hamilton MI, Walker A, Watkins JB, editors. Pediatric Gastrointestinal Disease. Hamilton, Ontario: B.C. Decker; 2000. p. 613-52.
44. Spray C, Debelle GD, Murphy MS. Current diagnosis, management and morbidity in paediatric inflammatory bowel disease. Acta Paediatr 2001;90:400-5.
45. Wagtmans MJ, Verspaget HW, Lamers CB, van Hogezand RA. Crohn's disease in the elderly: a comparison with young adults. J Clin Gastroenterol 1998;27:129-33.
46. Danzi JT. Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med 1988;148:297-302.
47. Hyams JS. Crohn's disease in children. Pediatr Clin North Am 1996;43:255-77.
48. Menachem Y, Weizman Z, Locker C, Odes S. Clinical characteristics of Crohn's disease in children and adults. Harefuah 1998;134:173-5, 247.
49. Gryboski JD, Spiro HM. Prognosis in children with Crohn's disease. Gastroenterol 1978;74:807-17.
50. Winesett M. Inflammatory bowel disease in children and adolescents. Pediatr Ann 1997;26:227-34.
51. Hofley P, Roarty J, McGinnity G, Griffiths AM, Marcon M, Kraft S, et al. Asymptomatic uveitis in children with chronic inflammatory bowel diseases. J Pediatr Gastroenterol Nutr 1993;17:397-400.
52. Burbige EJ, Huang SH, Bayless TM. Clinical manifestations of Crohn's disease in children and adolescents. Pediatrics 1975;55:866-71.
53. Lindsley C, JG S. Arthritis associated with inflammatory bowel disease in children. J Pediatr 1974;86:76.
54. Kane W, Miller K, Sharp HL. Inflammatory bowel disease presenting as liver disease during childhood. J Pediatr 1980;97:775-8.
55. Hyams J, Markowitz J, Treem W, Davis P, Grancher K, Daum F. Characterization of hepatic abnormalities in children with inflammatory bowel disease. Inflamm Bowel Dis 1995;1:27-33.
56. Faubion Jr WA, Loftus EV, Sandborn WJ, Freese DK, Perrault J. Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with PSC. J Pediatr Gastroenterol Nutr 2001;33:296-300.
57. McLeod RS, Churchill DN. Urolithiasis complicating inflammatory bowel disease. J Urol 1992;148:974-8.
58. Lloyd-Still JD, Tomasi L. Neurovascular and thromboembolic complications of inflammatory bowel disease in childhood. J Pediatr Gastroenterol Nutr 1989;9:461-6.
59. Hudson M, Chitolie A, Hutton RA, Smith MS, Pounder RE, Wakefield AJ. Thrombotic vascular risk factors in inflammatory bowel disease. Gut 1996;38:733-7.
60. Markowitz RL, Ment LR, Gryboski JD. Cerebral thromboembolic disease in pediatric and adult inflammatory bowel disease: case report and review of the literature. J Pediatr Gastroenterol Nutr 1989;8:413-20.
61. Reuner KH, Ruf A, Grau A, Rickmann H, Stolz E, Juttler E, et al. Prothrombin gene G20210:A transition is a risk factor for cerebral venous thrombosis. Stroke 1998;29:1765-9.
62. Harper PH, Fazio VW, Lavery IC, Jagelman DG, Weakley FL, Farmer RG, et al. The long-term outcome in Crohn's disease. Dis Colon Rectum 1987;30:174-9.
63. Barton JR, Ferguson A. Clinical features, morbidity and mortality of Scottish children with inflammatory bowel disease. Q J Med 1990;75:423-39.
64. Mamula P, Telega GW, Markowitz JE, Brown KA, Russo PA, Piccoli DA, et al. Inflammatory bowel disease in children 5 years of age and younger. Am J Gastroenterol 2002;97:2005-10.
65. Markowitz J, Daum F, Aiges H, Kahn E, Silverberg M, Fisher SE. Perianal disease in children and adolescents with Crohn's disease. Gastroenterol 1984;86:829-33.
66. Winter AM, Hanauer SB. Medical management of perianal Crohn's disease. Semin Gastrointest Dis 1998;9:10-4.
67. Rankin GB, Watts HD, Melnyk CS, Kelley Jr ML. National cooperative Crohn's disease study: extraintestinal manifestations and perianal complications. Gastroenterol 1979;77:914-20.
68. Schwartz DA, Pemberton JH, Sandborn WJ. Diagnosis and treatment of perianal fistulas in Crohn disease. Ann Intern Med 2001;135:906-18.
69. Homan WP, Tang C, Thorgjarnarson B. Anal lesions complicating Crohn's disease. Arch Surg 1976;111:1333-5.
70. Gray BK, Lockhartmummery HE, Morson BC. Crohn's disease of the anal region. Gut 1965;6:515-24.
71. Farmer RG, Hawk WA, Turnbull Jr RB. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterol 1975;68:627-35.
72. Ruuska T, Vaajalahti P, Arajarvi P, Maki M. Prospective evaluation of upper gastrointestinal mucosal lesions in children with ulcerative colitis and Crohn's disease. J Pediatr Gastroenterol Nutr 1994;19:181-6.
73. Cameron DJ. Upper and lower gastrointestinal endoscopy in children and adolescents with Crohn's disease: a prospective study. J Gastroenterol Hepatol 1991;6:355-8.
74. Veloso FT, Ferreira JT, Barros L, Almeida S. Clinical outcome of Crohn's disease: analysis according to the vienna classification and clinical activity. Inflamm Bowel Dis 2001;7:306-13.
75. Beaugerie L, Le Quintrec Y, Paris JC, Godchaux JM, Saint-Raymond A, Schmitz J, et al. Testing for course patterns in Crohn's disease using clustering analysis. Gastroenterol Clin Biol 1989;13:1036-41.
76. Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001;49:777-82.
77. Griffiths AM, Nguyen P, Smith C, MacMillan JH, Sherman PM. Growth and clinical course of children with Crohn's disease. Gut 1993;34:939-43.
78. Puntis J, McNeish AS, Allan RN. Long term prognosis of Crohn's disease with onset in childhood and adolescence. Gut 1984;25:329-36.
79. Michener WM, Whelan G, Greenstreet RL, Farmer RG. Comparison of the clinical features of Crohn's disease and ulcerative colitis with onset in childhood or adolescence. Cleve Clin Q 1982;49:13-6.
80. Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, et al. Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Gut 1996;39:690-7.
81. Holmquist L, Rudic N, Ahren C, Fallstrom SP. The diagnostic value of colonoscopy compared with rectosigmoidoscopy in children and adolescents with symptoms of chronic inflammatory bowel disease of the colon. Scand J Gastroenterol 1988;23:577-84.
82. Farmer RG, Easley KA, Rankin GB. Clinical patterns, natural history, and progression of ulcerative colitis. A long-term follow-up of 1116 patients. Dig Dis Sci 1993;38:1137-46.
83. Mir-Madjlessi SH, Michener WM, Farmer RG. Course and prognosis of idiopathic ulcerative proctosigmoiditis in young patients. J Pediatr Gastroenterol Nutr 1986;5:571-5.
84. Meucci G, Vecchi M, Astegiano M, Beretta L, Cesari P, Dizioli P, et al. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 2000;95:469-73.
85. Michener WM, Farmer RG, Mortimer EA. Long-term prognosis of ulcerative colitis with onset in childhood or adolescence. J Clin Gastroenterol 1979;1:301-5.
86. Hyams JS, Davis P, Grancher K, Lerer T, Justinich CJ, Markowitz J. Clinical outcome of ulcerative colitis in children. J Pediatr 1996;129:81-8.
87. Gryboski JD. Ulcerative colitis in children 10 years old or younger. J Pediatr Gastroenterol Nutr 1993;17:24-31.
88. Werlin SL, Grand RJ. Severe colitis in children and adolescents: diagnosis, course, and treatment. Gastroenterol 1977;73:828-32.
89. Ahsgren L, Jonsson B, Stenling R, Rutegard J. Prognosis after early onset of ulcerative colitis. A study from an unselected patient population. Hepatogastroenterology 1993;40:467-70.
90. Falcone Jr RA, Lewis LG, Warner BW. Predicting the need for colectomy in pediatric patients with ulcerative colitis. J Gastrointest Surg 2000;4:201-6.
91. Motil KJ, Grand RJ, Maletskos CJ, Young VR. The effect of disease, drug, and diet on whole body protein metabolism in adolescents with Crohn disease and growth failure. J Pediatr 1982;101:345-51.
92. Grill BB, Hillemeier AC, Gryboski JD. Fecal alpha 1-antitrypsin clearance in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1984;3:56-61.
93. Kelts D, Grand R, Shen G, Watkins J, Werlin S, Boehme C. Nutritional basis of growth failure in children and adolescents with Crohn's disease. Gastroenterol 1979;76:720-7.
94. Seidman E, LeLeiko N, Ament M, Berman W, Caplan D, Evans J, et al. Nutritional issues in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1991;12:424-38.
95. Kanof ME, Lake AM, Bayless TM. Decreased height velocity in children and adolescents before the diagnosis of Crohn's disease. Gastroenterol 1988;95:1523-7.
96. Rigaud D, Cosnes J, Le Quintrec Y, Rene E, Gendre J, Mignon M. Controlled trial comparing two types of enteral nutrition in treatment of active Crohn's disease: elemental vs, polymeric diet. Gut 1991;32:1492-7.
97. Sentongo T, Semeao E, Piccoli D, Stallings V, Zemel B. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr 2000;31:33-40.
98. Motil K, Grand R, Matthews D, Bier D, Maletskos C, Young V. Whole body leucine metabolism in adolescents with Crohn's disease and growth failure during nutritional supplementation. Gastroenterol 1982;82:1361-8.
99. Layden T, Rosenberg F, Nemchausky G, Elson C, Rosenberg I. Reversal of growth arrest in adolescents with Crohn's disease after parenteral alimentation. Gastroenterol 1976;70:1017-21.
100. Ferguson A, Glen M, Ghosh S. Crohn's disease: nutrition and nutritional therapy. Baillieres Clin Gastroenterol 1998;12:93-114.
101. Byrne W, Halpin T, Asch M, Fonkalsrud E, Ament M. Home total parenteral nutrition: an alternative approach to the management of children with severe chronic small bowel disease. J Ped Surg 1977;12:359-66.
102. Christie P, Hill G. Effect of intravenous nutrition on nutrition and function in acute attacks of inflammatory bowel disease. Gastroenterol 1990;99:730-6.
103. Kirschner B, Klich J, Kalman S, DeFavaro M, Rosenberg I. Reversal of growth retardation in Crohn's disease with therapy emphasizing oral nutritional restitution. Gastroenterol 1980;80:10-5.
104. Motil K. Aggressive nutritional therapy in growth retardation. Clin Nutr 1985;4:75-84.
105. Himes JH, Roche AF, Thissen D, Moore WM. Parent-specific adjustments for evaluation of recumbent length and stature of children. Pediatrics 1985;75:304-13.
106. Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, et al. Development and validation of pediatric Crohn's Disease Activity Index. J Pediatr Gastroenterol Nutr 1991;12:439-47.
107. Otley A, Loonen H, Parekh N, Corey M, Sherman PM, Griffiths AM. Assessing activity of pediatric Crohn's disease: Which index to use? Gastroenterol 1999;116:527-31.
108. Rosen DS. Pubertal growth and sexual maturation for adolescents with chronic illness or disability. Pediatrician 1991;18:105-20.
109. Brain CE, Savage MO. Growth and puberty in chronic inflammatory bowel disease. Baillieres Clin Gastroenterol 1994;8:83-100.
110. Tanner JM. Growth at Adolescence. Oxford: Blackwell Scientific; 1972.
111. de Vizia B, Poggi V, Conenna R, Fiorillo A, Scippa L. Iron absorption and iron deficiency in infants and children with gastrointestinal diseases. J Pediatr Gastroenterol Nutr 1992;14:21-6.
112. Galloway R, McGuire J. Determinants of compliance with iron supplementation: supplies, side effects, or psychology? Soc Sci Med 1994;39:381-90.
113. NIH. Osteoporosis prevention. Diagnosis, and Therapy Consensus Statement, 2000:1-45.
114. Leonard MB, Zemel BS. Current concepts in pediatric bone disease. Pediatr Clin N Am 2002;49:143-73.
115. Compston JE, Creamer B. Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut 1977;18:171-5.
116. Schulte CM, Dignass AU, Goebell H, Roher HD, Schulte KM. Genetic factors determine extent of bone loss in inflammatory bowel disease. Gastroenterol 2000;119:909-20.
117. Nemetz A, Toth M, Garcia-Gonzalez MA, Zagoni T, Feher J, Pena AS, et al. Allelic variation at the interleukin 1beta gene is associated with decreased bone mass in patients with inflammatory bowel diseases. Gut 2001;49:644-9.
118. Caniggia A, Nuti R, Lore F, Vattimo A. Pathophysiology of the adverse effects of glucoactive corticosteroids on calcium metabolism in man. J Steroid Biochem 1981;15:153-61.
119. Suzuki Y, Ichikawa Y, Saito E, Homma M. Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 1983;32:151-6.
120. Lukert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990;112:352-64.
121. Schoon EJ, Geerling BG, Van Dooren IM, Schurgers LJ, Vermeer C, Brummer RJ, et al. Abnormal bone turnover in long-standing Crohn's disease in remission. Aliment Pharmacol Ther 2001;15:783-92.
122. LoCascio V, Adami S, Avioli LV, Cominacini L, Galvanini G, Gennari C, et al. Suppressive effect of chronic glucocorticoid treatment on circulating calcitonin in man. Calcif Tissue Int 1982;34:309-10.
123. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1994;18:165-73.
124. Thearle M, Horlick M, Bilezikian JP, Levy J, Gertner JM, Levine LS, et al. Osteoporosis: an unusual presentation of childhood Crohn's disease. J Clin Endocrinol Metab 2000;85:2122-6,
125. Semeao EJ, Jawad AF, Zemel BS, Neiswender KM, Piccoli DA, Stallings VA. Bone mineral density in children and young adults with Crohn's disease. Inflamm Bowel Dis 1999;5:161-6,
126. Semeao EJ, Jawad AF, Stouffer NO, Zemel BS, Piccoli DA, Stallings VA. Risk factors for low bone mineral density in children and young adults with Crohn's disease. J Pediatr 1999;135:593-600.
127. Johnston C, Miller J, Slemenda C, Reister T, Hui S, Christian J, et al. Calcium supplementation and increases in bone mineral density in children. N Engl J Med 1992;327:82-7.
128. Lee W, Leung S, Wang S-H, Xu Y-C, Zeng W-P, Lau J, et al. Double-blind, controlled calcium supplementation and bone mineral accretion in children accustomed to a low-calcium diet. Am J Clin Nutr 1994;60:744-50.
129. Lee W, Leung S, Leung D, Cheng J. A follow-up study on the effects of calcium-supplement withdrawal and puberty on bone acquisition of children. Am J Clin Nutr 1996;64:71-7.
130. Chan G, Hoffman K, McMurry M. Effects of dairy products on bone and body composition in pubertal girls. J Pediatr 1995;126:551-6.
131. Lloyd T, Andon M, Rollings N, Martel J, Landis J, Demers L, et al. Calcium supplementation and bone mineral density in adolescent girls. JAMA 1993;270:841-4.
132. Robinson RJ, Iqbal SJ, Abrams K, Al-Azzawi F, Mayberry JF. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther 1998;12:699-705.
133. Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, et al. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 1998;339:292-9.
134. Adachi JD, Bensen WG, Brown J, Hanley D, Hodsman A, Josse R, et al. Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997;337:382-7.
135. Haderslev KV, Tjellesen L, Sorensen HA, Staun M. Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease. Gastroenterol 2000;119:639-46.
136. Brumsen C, Hamdy N, Papapoulos S. Long-term effects of bisphosphonates on the growing skeleton: studies of young patients with severe osteoporosis. Medicine (Baltimore) 1997;76:266-83.
137. Astrom E, Soderhall S. Beneficial effect of long term intravenous bisphosphonate treatment of osteogenesis imperfecta. Arch Dis Child 2002;86:356-64.
138. Ferry GD. Quality of life in inflammatory bowel disease: background and definitions. J Pediatr Gastroenterol Nutr 1999;28:S15-8.
139. Maunder RG, Cohen Z, McLeod RS, Greenberg GR. Effect of intervention in inflammatory bowel disease on health-related quality of life: a critical review. Dis Colon Rectum 1995;38:1147-61.
140. Yacavone RF, Locke 3rd GR, Provenzale DT, Eisen GM. Quality of life measurement in gastroenterology: what is available? Am J Gastroenterol 2001;96:285-97.
141. Pallis AG, Mouzas IA. Instruments for quality of life assessment in patients with inflammatory bowel disease. Dig Liver Dis 2000;32:682-8.
142. Casellas F, Lopez-Vivancos J, Vergara M, Malagelada J. Impact of inflammatory bowel disease on health-related quality of life. Dig Dis 1999;17:208-18.
143. Koot HM, Bouman NH. Potential uses for quality-of-life measures in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999;28:S56-61.
144. Irvine EJ. Quality of life issues in patients with inflammatory bowel disease. Am J Gastroenterol 1997;92:18S-24S.
145. Sandborn WJ, Feagan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterol 2002;122:512-30.
146. Akobeng AK, Suresh-Babu MV, Firth D, Miller V, Mir P, Thomas AG. Quality of life in children with Crohn's disease: a pilot study. J Pediatr Gastroenterol Nutr 1999;28:S37-9.
147. Rabbett H, Elbadri A, Thwaites R, Northover H, Dady I, Firth D, et al. Quality of life in children with Crohn's disease. J Pediatr Gastroenterol Nutr 1996;23:528-33.
148. Griffiths AM, Nicholas D, Smith C, Munk M, Stephens D, Durno C, et al. Development of a quality-of-life index for pediatric inflammatory bowel disease: dealing with differences related to age and IBD type. J Pediatr Gastroenterol Nutr 1999;28:S46-52.
149. Lavigne JV, Faier-Routman J. Psychological adjustment to pediatric physical disorders: a meta-analytic review. J Pediatr Psychol 1992;17:133-57,
150. Akobeng AK, Miller V, Firth D, Suresh-Babu MV, Mir P, Thomas AG. Quality of life of parents and siblings of children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1999;28:S40-2.
151. Ringel Y, Drossman DA. Psychosocial aspects of Crohn's disease. Surg Clin North Am 2001;81:231-52.
152. Spirito A, Stark LJ, Williams C. Development of a brief coping checklist for use with pediatric populations. J Pediatr Psychol 1988;13:555-74.
153. Harbeck-Weber C, McKee DH. Prevention of emotional and behavioral distress in children experiencing hospitalization and chronic illness. In: Roberts MC, editor. Handbook of Pediatric Psychology. New York: Guilford Publications; 1995. p. 167-84.
154. Tobin DL, Holroyd KA, Reynolds RV, Wigal JK. The hierarchical factor structure of the coping strategies inventory. Cognitive Ther & Res 1989;13:343-61.
155. MacPhee M, Hoffenberg EJ, Feranchak A. Quality-of-life factors in adolescent inflammatory bowel disease. Inflamm Bowel Dis 1998;4:6-11.
156. Gillman JB. Inflammatory bowel diseases: psychological issues. In: Olson RA, Mullins LL, Gillman JB, Chaney JM, editors. The Sourcebook of Pediatric Psychology. Boston: Allyn & Bacon; 1994. p. 135-44.
157. A consensus statement on health care transitions for young adults with special health care needs. Pediatrics 2002;110:1304-6.
158. Blum RW, Garell D, Hodgman CH, Jorissen TW, Okinow NA, Orr DP, et al. Transition from child-centered to adult health-care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine. J Adolesc Health 1993;14:570-6.
159. Betz CL. Facilitating the transition of adolescents with chronic conditions from pediatric to adult health care and community settings. Issues Compr Pediatr Nurs 1998;21:97-115.
160. Rosen D. Between two worlds: bridging the cultures of child health and adult medicine. J Adolesc Health 1995;17:10-6.
161. Sawyer SM, Blair S, Bowes G. Chronic illness in adolescents: transfer or transition to adult services? J Paediatr Child Health 1997;33:88-90.
162. American Academy of Pediatrics Committee on Children with Disabilities and Committee on Adolescence. Transition of care provided for adolescents with special health care needs. Pediatrics 1996;98:1203-6.
163. Scal P. Transition for youth with chronic conditions: primary care physicians' approaches. Pediatrics 2002;110:1315-21.
164. Baldassano R, Ferry G, Griffiths A, Mack D, Markowitz J, Winter H. Transition of the patient with inflammatory bowel disease from pediatric to adult care: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2002;34:245-8.